1. Home
  2. MAIA vs MPU Comparison

MAIA vs MPU Comparison

Compare MAIA & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • MPU
  • Stock Information
  • Founded
  • MAIA 2018
  • MPU 1989
  • Country
  • MAIA United States
  • MPU Singapore
  • Employees
  • MAIA N/A
  • MPU N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • MPU Transportation Services
  • Sector
  • MAIA Health Care
  • MPU Consumer Discretionary
  • Exchange
  • MAIA Nasdaq
  • MPU Nasdaq
  • Market Cap
  • MAIA 56.3M
  • MPU 35.5M
  • IPO Year
  • MAIA 2022
  • MPU 1998
  • Fundamental
  • Price
  • MAIA $1.71
  • MPU $2.01
  • Analyst Decision
  • MAIA
  • MPU
  • Analyst Count
  • MAIA 0
  • MPU 0
  • Target Price
  • MAIA N/A
  • MPU N/A
  • AVG Volume (30 Days)
  • MAIA 540.2K
  • MPU 1.2M
  • Earning Date
  • MAIA 08-08-2025
  • MPU 08-13-2025
  • Dividend Yield
  • MAIA N/A
  • MPU N/A
  • EPS Growth
  • MAIA N/A
  • MPU N/A
  • EPS
  • MAIA N/A
  • MPU N/A
  • Revenue
  • MAIA N/A
  • MPU $35,228,600.00
  • Revenue This Year
  • MAIA N/A
  • MPU N/A
  • Revenue Next Year
  • MAIA N/A
  • MPU N/A
  • P/E Ratio
  • MAIA N/A
  • MPU N/A
  • Revenue Growth
  • MAIA N/A
  • MPU 305.32
  • 52 Week Low
  • MAIA $1.40
  • MPU $0.49
  • 52 Week High
  • MAIA $4.24
  • MPU $2.67
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 43.93
  • MPU 62.83
  • Support Level
  • MAIA $1.80
  • MPU $1.82
  • Resistance Level
  • MAIA $2.15
  • MPU $2.25
  • Average True Range (ATR)
  • MAIA 0.12
  • MPU 0.36
  • MACD
  • MAIA -0.01
  • MPU 0.07
  • Stochastic Oscillator
  • MAIA 20.91
  • MPU 64.57

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About MPU Mega Matrix Corp.

Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.

Share on Social Networks: